Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS

Samlyn Capital, LLC reported a 6.00% stake in Corvus Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Samlyn Capital, LLC reported a 6.00% stake in Corvus Pharmaceuticals, Inc., 4,065,935 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
6.00%
Shares
4,065,935
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
SAMLYN CAPITAL, LLC6.00%4,065,935
SAMLYN, LP6.00%4,065,935
ROBERT POHLY6.00%4,065,935

Source

View original at SEC

Related